Bio Green Med Solution, Inc. (BGMS)
NASDAQ: BGMS · Real-Time Price · USD
0.8732
-0.0391 (-4.29%)
Aug 19, 2026, 11:39 AM EDT - Market open

Bio Green Med Solution Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.860.750.040.42--
Revenue Growth
18510.00%1637.21%-89.76%---
Gross Profit
-0.39-0.67-6.52-18.3--
Operating Income
-3.56-8.43-12-25.45-27.66-22.39
Net Income
-13.32-14.09-11.21-22.76-21.4-18.66
Earnings Per Share
-2.95-6.45-502.46---
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
3.793.513.143.3818.3536.56
Total Debt
-0.02-0.040.110.03
Net Cash (Debt)
3.793.493.143.3418.2436.53
Net Cash Growth
-11.14%11.09%-6.11%-81.68%-50.07%12.92%
Net Cash Per Share
0.841.59140.58---

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
--4.77-7.99-16.11-20.83-18.54
Capital Expenditures
----0.01-0.01-0.03
Free Cash Flow
--4.77-7.99-16.12-20.83-18.57
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-20.85%-90.09%----
Operating Margin
-191.29%-1128.11%-27916.28%-6060.24%--
Pretax Margin
105.75%-400.40%-27893.02%-6083.57%--
Profit Margin
-715.48%-1886.48%-26074.42%-5418.10%--
FCF Margin
--638.55%-18581.40%-3837.62%--

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
2.589.7154.986.48--